Epigene Labs
Paris, France
Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion. The Epigene Labs technology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches. With R&D in Paris and business development in Boston, the company operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- www.epigenelabs.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Epigene Labs?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now